GlassScriptPhysician profile
Amjad Q Syed
NPI 1932367083
$30,774.20
in general payments reported to CMS, 2019-2025
26 companies · $3,473 in 2025
The $3,473 reported for 2025 was more than what 77% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,505 · 2020: $6,381 · 2021: $4,906 · 2022: $2,066 · 2023: $9,191 · 2024: $1,253 · 2025: $3,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,750 · Travel and Lodging: $3,761 · Food and Beverage: $3,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,750.00 |
| Travel and Lodging | $3,760.84 |
| Food and Beverage | $3,405.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $14,062.01 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Intuitive Surgical, INC. | $8,603.62 | 2020-2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $2,373.52 | 2022-2025 | Avalus, Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $1,365.00 | 2021-2024 | Mitraclip, Diamondback Coronary, 2nd Gen Centrimag Primary Console |
| Artivion, INC. | $1,276.64 | 2025 | Amds-Ascyrus Medical |
| W. L. Gore & Associates, INC. | $729.53 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Zimmer Biomet Holdings, INC. | $639.69 | 2019-2025 | Advantagerib, Ribfix Blu Advantage, Ribfix Titan |
| Atricure, INC. | $270.46 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Abiomed | $257.43 | 2024-2025 | Impella |
| Ethicon INC. | $186.83 | 2020-2024 | Monarch Platform |
| Cvrx, INC. | $161.91 | 2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $123.74 | 2019 | |
| Ethicon US, LLC | $123.54 | 2019-2024 | Echelon; Endopath, Prolene, Vistaseal |
| Cook Medical LLC | $114.88 | 2020 | |
| Shockwave Medical, INC | $108.14 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $79.94 | 2019-2020 | |
| Boston Scientific Corporation | $66.23 | 2022 | |
| Lsi Solutions INC | $43.58 | 2023-2025 | Cor Knot, Cor-Knot |
| Getinge USA Sales, LLC | $35.05 | 2021-2022 | |
| Kls-Martin L.P. | $30.83 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.00 | 2020 | |
| Davol INC. | $24.07 | 2021 | |
| Solventum Corporation | $19.59 | 2024 | Activ.A.C. |
| Novartis Pharmaceuticals Corporation | $18.55 | 2020 | |
| Arjo INC. | $16.51 | 2025 | |
| Sanara Medtech INC. | $13.91 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amjad Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.